Microdosing Ozempic for Weight Loss
The article discusses the trend of microdosing the diabetes medication Ozempic for weight loss, despite it not being approved by the FDA. Experts caution against the practice due to potential risks and lack of proven effectiveness.
Key Points
- Microdosing Ozempic involves using smaller amounts than traditional therapeutic doses
- Cost reduction and side effect management are common reasons for microdosing
- Lack of FDA approval and clinical studies pose risks to effectiveness and safety
Pros
- Potential cost savings compared to standard doses
- Possibility of reducing side effects like nausea and vomiting
- Gradual acclimation to medication for some individuals
Cons
- Not approved by the FDA
- Lack of established guidelines for microdosing
- Risk of ineffective treatment and uncontrolled diabetes
- Potential for misuse and unpredictable results